{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:06:21Z","timestamp":1793833581355,"version":"4.6.1"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.vaccine.2011.07.121","type":"journal-article","created":{"date-parts":[[2011,9,7]],"date-time":"2011-09-07T14:21:32Z","timestamp":1315405292000},"page":"C15-C25","source":"Crossref","is-referenced-by-count":11,"special_numbering":"S3","title":["Prevention of pneumococcal disease through vaccination"],"prefix":"10.1016","volume":"29","author":[{"given":"Angela","family":"Gentile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Baz\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.07.121_bib0005","unstructured":"WHO. Millennium Development Goals (MDGs). http:\/\/www.who.int\/topics\/millennium_development_goals\/about\/en\/index.html [accessed 5.10.11]."},{"key":"10.1016\/j.vaccine.2011.07.121_bib0010","unstructured":"United Nations Development Program. http:\/\/www.beta.undp.org\/undp\/en\/home\/ourwork\/povertyreduction\/focus_areas\/focus_mdg_strategies.html [accessed 06.23.11]."},{"key":"10.1016\/j.vaccine.2011.07.121_bib0015","unstructured":"Millennium Development Goals Indicators. http:\/\/unstats.un.org\/unsd\/mdg\/Host.aspx?Content=Indicators\/OfficialList.htm [accessed 06.25.11]."},{"key":"10.1016\/j.vaccine.2011.07.121_bib0020","series-title":"Identifying priorities for child health research to achieve Millennium Development Goal 4 Consultation Proceedings","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0025","series-title":"The Millennium Development Goals and the United Nations role","author":"United Nations Department of Public Information","year":"2002"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0030","unstructured":"World Health Organization. UNICEF global action plan for prevention and control of pneumonia (GAPP). WHO\/FCH\/CAH\/NCH\/09.04."},{"key":"10.1016\/j.vaccine.2011.07.121_bib0035","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/01.inf.0000222403.42974.8b","article-title":"Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects","volume":"25","author":"Ray","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0040","unstructured":"United Nations. The Millennium Development Goal report, 2010. Goal 4. Reduce childhood mortality. http:\/\/mdgs.un.org\/unsd\/mdg\/Resources\/Static\/Products\/Progress2010\/2010_Addendum_Goal4.pdf [accessed 06.26.11]."},{"key":"10.1016\/j.vaccine.2011.07.121_bib0045","doi-asserted-by":"crossref","unstructured":"Nayer. Pneumococcal vaccine rolls out in developing world. Nature News. http:\/\/www.nature.com\/news\/2011\/110211\/full\/news.2011.89.html [accessed 6.09.11].","DOI":"10.1038\/news.2011.89"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0050","series-title":"Improving global health by preventing pneumococcal disease. Report from the All-Party Parliamentary Group on Pneumococcal Disease Prevention in the Developing World","author":"GAVI Alliance","year":"2008"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0055","series-title":"Global immunization data","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0140-6736(03)13811-1","article-title":"How many child deaths can we prevent this year?","volume":"362","author":"Jones","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0065","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1473-3099(03)00737-0","article-title":"Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials","volume":"3","author":"Sazawal","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"5915","key":"10.1016\/j.vaccine.2011.07.121_bib0070","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.323.5915.700","article-title":"Global health: some neglected diseases are more neglected than others","volume":"323","author":"Enserink","year":"2009","journal-title":"Science"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.07.121_bib0075","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2471\/BLT.08.050872","article-title":"Comparative impact assessment of child pneumonia interventions","volume":"87","author":"Niessen","year":"2009","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0080","series-title":"Expert group report","author":"Advance Market Commitment for Pneumococcal Vaccines","year":"2008"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0085","unstructured":"Constenla D, Gomez E, de la Hoz FP, O\u2019Loughlin R, Sinha A, Valencia JE, et al. The burden of pneumococcal disease and cost-effectiveness of a pneumococcal vaccine. A review of the evidence and an preliminary economic evaluation. http:\/\/new.paho.org\/provac\/index2.php?option=com_docman&task=doc_view&gid=2240&Itemid=99999999 [accessed 06.23.11]."},{"issue":"2","key":"10.1016\/j.vaccine.2011.07.121_bib0090","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1590\/S0102-311X2004000200008","article-title":"Population-based surveillance of pediatric pneumonia: use of spatial analysis in an urban area of Central Brazil","volume":"20","author":"Andrade","year":"2004","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0095","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1590\/S1020-49892006000500007","article-title":"Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction","volume":"19","author":"Garcia","year":"2006","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0100","unstructured":"PAHO. http:\/\/hist.library.paho.org\/English\/ACHR\/ACHR29_93_6.pdf; 1993 [accessed 06.23.11]."},{"key":"10.1016\/j.vaccine.2011.07.121_bib0105","series-title":"Organizaci\u00f3n Panamericana de la Salud Informe Regional de SIREVA II, 2009: datos por pa\u00eds y por grupos de edad sobre las caracter\u00edsticas de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis en procesos invasores","year":"2010"},{"issue":"3","key":"10.1016\/j.vaccine.2011.07.121_bib0110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijid.2006.05.006","article-title":"A population-based assessment of the disease burden of consolidated pneumonia in hospitalized children under five years of age","volume":"11","author":"Hortal","year":"2007","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0115","first-page":"353","article-title":"Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies","volume":"83","author":"Cherian","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0120","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1590\/S1020-49892003000400004","article-title":"Uso de la radiograf\u00eda de t\u00f3rax para la vigilancia de las neumon\u00edas bacterianas en ni\u00f1os latinoamericanos","volume":"13","author":"Lagos","year":"2003","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0125","series-title":"Congreso Argentino de Infectolog\u00eda Pedi\u00e1trica, Jornada de la Sociedad Latinoamericana de Infectolog\u00eda Pedi\u00e1trica (SLIPE) \u2013 Cono Sur 16 al 19 de Abril de 2008","article-title":"Carga de neumon\u00eda consolidante en ni\u00f1os menores de 5 a\u00f1os en el partido de pilar (Poster 106)","author":"Gentile","year":"2008"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0130","series-title":"An inquiry into the causes and effects of the Variolae Vaccinae","author":"Jenner","year":"1798"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0135","series-title":"The achievement of the global eradication of smallpox","author":"Global Commission for the Certification of Smallpox Eradication","year":"1979"},{"issue":"49","key":"10.1016\/j.vaccine.2011.07.121_bib0140","first-page":"441","article-title":"Progress in global measles control and mortality reduction, 2000\u20132007","volume":"83","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0145","series-title":"Global elimination of measles. Report by the Secretariat. Executive Board, Geneva, 16 April 2009","year":"2009"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0150","series-title":"Disease control priorities in developing countries","year":"2006"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0155","series-title":"Control of communicable diseases manual","year":"2004"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0160","series-title":"The Jordan report: accelerated development of vaccines, 2007","year":"2007"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0165","unstructured":"World Health Organization. The initiative for vaccine research: strategic plan 2006\u20132009. http:\/\/www.who.int\/vaccines-documents\/DocsPDF06\/854.pdf [accessed 6.08.11]."},{"issue":"5","key":"10.1016\/j.vaccine.2011.07.121_bib0170","first-page":"38","article-title":"Meeting of the Global Advisory Committee on Vaccine Safety, December 2010","volume":"86","author":"World Health Organization","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0175","unstructured":"World Health Organization. Immunization safety. Monitoring immunization safety. Vaccine safety and quality. http:\/\/www.who.int\/immunization_safety\/monitoring\/quality_safety_waste_management\/en\/index.html [accessed 6.08.11]."},{"key":"10.1016\/j.vaccine.2011.07.121_bib0180","series-title":"Vaccine safety research, data access, and public trust","author":"Institute of Medicine","year":"2005"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0185","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1542\/peds.2010-1722H","article-title":"The Vaccine Safety Datalink: a model for monitoring immunization safety","volume":"127","author":"Baggs","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0190","series-title":"Vaccines","first-page":"17","article-title":"Vaccine immunology","author":"Siegrist","year":"2008"},{"issue":"4 Suppl.","key":"10.1016\/j.vaccine.2011.07.121_bib0195","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1038\/nm1216","article-title":"Can successful vaccines teach us how to induce efficient protective immune responses","volume":"11","author":"Lambert","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0200","series-title":"Protegiendo la Salud de las Am\u00e9ricas: Avanzando de la vacunaci\u00f3n de los ni\u00f1os a la de la familia","author":"Organizaci\u00f3n Panamericana de la Salud","year":"2006"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0205","series-title":"A report from the American Academy of Microbiology. Vaccines developments: current status and future needs","author":"Kaper","year":"2005"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0210","series-title":"GIVS: global immunization vision and strategy 2006\u20132015","author":"World Health Organization & United Nations Children's Fund","year":"2005"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0215","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jama.293.10.1204","article-title":"Timeliness of childhood vaccinations in the United States: days undervaccinated and number of vaccines delayed","volume":"293","author":"Luman","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2011.07.121_bib0220","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00124784-199600210-00005","article-title":"Missed opportunities for immunizations: a review of the evidence","volume":"2","author":"Szilagyi","year":"1996","journal-title":"J Public Health Manag Pract"},{"issue":"5","key":"10.1016\/j.vaccine.2011.07.121_bib0225","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1067\/mpd.2001.117069","article-title":"Immunization recall: effectiveness and barriers to success in an urban teaching clinic","volume":"139","author":"Kempe","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0230","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1542\/peds.110.5.935","article-title":"Timeliness of childhood immunizations","volume":"110","author":"Luman","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0235","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00006454-199602000-00010","article-title":"Knowledge of the childhood immunization schedule and of contraindications to vaccinate by private and public providers in Los Angeles","volume":"15","author":"Wood","year":"1996","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2011.07.121_bib0240","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1592\/phco.2005.25.9.1193","article-title":"Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention","volume":"25","author":"Bridy-Pappas","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0245","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/01.inf.0000220231.79968.f6","article-title":"Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis","volume":"25","author":"Shouval","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0250","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/JCM.02199-06","article-title":"Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae","volume":"45","author":"Park","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0255","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1099\/mic.0.024521-0","article-title":"Production of a unique pneumococcal capsule serotype belonging to serogroup 6","volume":"155","author":"Bratcher","year":"2009","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0260","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.carres.2003.07.008","article-title":"Immunology of bacterial polysaccharide antigens","volume":"338","author":"Weintraub","year":"2003","journal-title":"Carbohydr Res"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2011.07.121_bib0265","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/IAI.40.1.245-256.1983","article-title":"Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates","volume":"40","author":"Chu","year":"1983","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0270","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/978-1-4615-1267-7_30","article-title":"Bacterial polysaccharides as vaccines\u2014immunity and chemical characterization","volume":"491","author":"Lee","year":"2001","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0275","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4049\/jimmunol.176.1.529","article-title":"CD4+ T lymphocytes expressing CD40 ligand help the IgM antibody response to soluble pneumococcal polysaccharides via an intermediate cell type","volume":"176","author":"Jeurissen","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0280","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1073\/pnas.0501254102","article-title":"CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization","volume":"102","author":"Malley","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0285","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.4049\/jimmunol.174.4.1787","article-title":"Cutting edge: antibody production to pneumococcal polysaccharides requires CD1 molecules and CD8+ T cells","volume":"174","author":"Kobrynski","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.07.121_bib0290","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3201\/eid0506.990616","article-title":"Effectiveness of pneumococcal polysaccharide vaccine for preschool-age children with chronic disease","volume":"5","author":"Fiore","year":"1999","journal-title":"Emerg Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2011.07.121_bib0295","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S0264-410X(99)00232-7","article-title":"Glycoprotein conjugate vaccines","volume":"17","author":"Lindberg","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0300","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1586\/14760584.2.5.633","article-title":"Conjugate vaccines","volume":"2","author":"Lockhart","year":"2003","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0305","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.autrev.2005.04.005","article-title":"CD4+ regulatory T cells: mechanisms of induction and effector function","volume":"4","author":"Bacchetta","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0310","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1586\/14760584.3.1.23","article-title":"Antibody regulation of T-cell immunity: implications for vaccine strategies against intracellular pathogens","volume":"3","author":"Igietseme","year":"2004","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2011.07.121_bib0315","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1586\/14760584.5.5.651","article-title":"Nasopharyngeal colonization: a target for pneumococcal vaccination","volume":"5","author":"K\u00e4yhty","year":"2006","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0320","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(01)00063-9","article-title":"Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance","volume":"1","author":"Klugman","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0325","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CVI.13.2.165-169.2006","article-title":"Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines","volume":"131","author":"Romero-Steiner","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0330","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization\u2014WHO position paper","volume":"82","author":"World Health Organization","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0335","series-title":"WHO technical report series: fifty-fourth report","author":"World Health Organization Expert Committee on Biological Standardization","year":"2005"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0340","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization\u2014WHO position paper","volume":"82","author":"World Health Organization","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0345","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0350","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0355","first-page":"255","article-title":"Efficacy and safety of sevenvalent conjugate pneumococcal vaccine in American Indian children: group randomized trial","volume":"362","author":"O\u2019Brien","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0360","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/00006454-200209000-00005","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia","volume":"21","author":"Black","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0365","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/01.inf.0000232706.35674.2f","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs","volume":"25","author":"Hansen","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0370","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.vaccine.2009.10.121","article-title":"Declining invasive pneumococcal disease mortality in the United States, 1990\u20132005","volume":"28","author":"Pulido","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0375","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1001\/jama.298.18.2155","article-title":"Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States","volume":"298","author":"Roush","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0380","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0385","first-page":"144","article-title":"Invasive PD in children 5 years after conjugate vaccine introduction\u2014eight states, 1998\u20132005","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0390","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Active Bacterial Core Surveillance\/Emerging Infections Program Network. Sustained reductions in invasive PD in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0395","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive PD: a matched case\u2013control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0400","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0b013e3182152bf1","article-title":"Impact of universal pneumococcal vaccination on hospitalizations for pneumonia and meningitis in children in Montevideo, Uruguay","author":"P\u00edrez","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0405","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/INF.0b013e31817cf76f","article-title":"Pneumonia after implementation of the pneumococcal conjugate vaccine program in the province of Quebec, Canada","volume":"27","author":"De Wals","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0410","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/archpedi.161.12.1162","article-title":"Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States","volume":"161","author":"Zhou","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0415","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunization with pneumococcal conjugate vaccine in the USA: a time-series analysis","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0420","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1016\/j.vaccine.2008.08.058","article-title":"Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations","volume":"26","author":"Adam","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0425","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jama.2009.1163","article-title":"Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings","volume":"307","author":"Grijalva","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0430","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/01.inf.0000133049.30299.5d","article-title":"The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children","volume":"23","author":"Palmu","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0435","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1542\/peds.2006-2138","article-title":"Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine","volume":"119","author":"Poehling","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0440","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/INF.0b013e31819e9bc5","article-title":"The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia","volume":"28","author":"Jardine","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0445","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1177\/147323000803600612","article-title":"Decline in pneumonia and acute otitis media after the introduction of childhood pneumococcal vaccination in Liguria, Italy","volume":"36","author":"Ansaldi","year":"2008","journal-title":"J Int Med Res"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0450","first-page":"1","article-title":"Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine\u2014United States, 1997\u20132006","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0455","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0460","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.inf.0000129685.04847.94","article-title":"Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente","volume":"23","author":"Black","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0465","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/422653","article-title":"Reduction in high rates of antibiotic-nonsusceptible invasive PD in Tennessee after introduction of the pneumococcal conjugate vaccine","volume":"39","author":"Talbot","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0470","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1542\/peds.2006-0492","article-title":"National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States","volume":"118","author":"Grijalva","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0475","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1542\/peds.2007-0619","article-title":"Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997\u20132004","volume":"121","author":"Zhou","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0480","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/503805","article-title":"Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive PD","volume":"193","author":"Hammitt","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0485","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease\u2014United States, 1998\u20132003","volume":"54","author":"Centers for Disease Control and Prevention (CDC)","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0490","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0495","series-title":"SIREVA Informe Regional de SIREVA II, 2009: Datos por pa\u00eds y por grupos de edad sobre las caracter\u00edsticas de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasores. Washington, DC","year":"2010"},{"issue":"4","key":"10.1016\/j.vaccine.2011.07.121_bib0500","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/01.inf.0000208368.67448.51","article-title":"Active epidemiologic surveillance of pneumonia and invasive pneumococcal disease in ambulatory and hospitalized infants in Cordoba, Argentina","volume":"25","author":"Tregnaghi","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2011.07.121_bib0505","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1590\/S1020-49892000000800006","article-title":"Impact of Streptococcus pneumoniae on pneumonia in Latin American children. SIREVA-Vig\u00eda Group","volume":"8","author":"Hortal","year":"2000","journal-title":"Rev Panam Salud Publica"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2011.07.121_bib0510","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0264-410X(02)00806-X","article-title":"Invasive pneumococcal diseases in Uruguayan children: comparison between serotype distribution and conjugate vaccine formulations","volume":"21","author":"Camou","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2011.07.121_bib0515","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1590\/S0036-46651994000300010","article-title":"Etiology and severity of community acquired pneumonia in children from Uruguay: a 4-year study","volume":"36","author":"Hortal","year":"1994","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0520","series-title":"ICAAC 2005, Poster, abstract","article-title":"Surveillance of probably bacterial pneumonia (PBP) in children less than 5 years old in Argentina","author":"Gentile","year":"2005"},{"issue":"3","key":"10.1016\/j.vaccine.2011.07.121_bib0525","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3233\/JPI-2010-0261","article-title":"Surveillance of invasive in Streptococcus pneumoniae in Argentina 1994\u20132007: changes in serotype distribution, serotype coverage of pneumococcal conjugate vaccines and antibiotic resistance","volume":"5","author":"Ruvinsky","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0530","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2006.09.009","article-title":"The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease","volume":"25","author":"Hausdorff","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0535","doi-asserted-by":"crossref","first-page":"a2964","DOI":"10.1136\/bmj.a2964","article-title":"Outbreak of Streptococcus pneumoniae serotype 1 pneumonia in a United Kingdom school","volume":"337","author":"Gupta","year":"2008","journal-title":"BJM"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0540","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1086\/313645","article-title":"An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel","volume":"30","author":"Dagan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0545","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/591128","article-title":"Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population","volume":"47","author":"Romney","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0550","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)01280-6","article-title":"Epidemiological differences among pneumococcal serotypes","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0555","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2011.07.121_bib0560","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.07.121_bib0565","first-page":"511","article-title":"Vaccine preventable deaths and the global immunization vision and strategy, 2006\u20132015","volume":"55","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11011716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T08:39:05Z","timestamp":1592901545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11011716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":113,"alternative-id":["S0264410X11011716"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.07.121","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}